Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns
Phase 4
Completed
- Conditions
- Wound HealingScar Formation
- Interventions
- Device: Autologous skinDevice: Wound coverage by acellular skin substitute
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2011-10-19
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 18
- Registration Number
- NCT01454310
- Locations
- 🇦🇹
Medical University of Vienna, Burn Center, Department of Plastic and Reconstructive Surgery, Vienna, Austria
Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy
Phase 2
Completed
- Conditions
- Birch Pollen Related Apple AllergyBirch Pollen Allergy
- Interventions
- Drug: rMal d 1Drug: rBet v 1Other: placebo drops
- First Posted Date
- 2011-10-10
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT01449786
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation
Phase 4
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Corvert (Ibutilide)Drug: Brinavess (Vernakalant)
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 101
- Registration Number
- NCT01447862
- Locations
- 🇦🇹
Medical University of Vienna, Department of Emergency Medicine, Vienna, Austria
Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length
Phase 4
Completed
- Conditions
- Menorrhagia
- First Posted Date
- 2011-09-20
- Last Posted Date
- 2013-03-08
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 290
- Registration Number
- NCT01436903
- Locations
- 🇦🇹
Landesklinikum Thermenregion Neunkirchen, Neunkirchen, Lower Austria, Austria
Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma
Completed
- Conditions
- Pheochromocytoma
- First Posted Date
- 2011-08-30
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 15
- Registration Number
- NCT01425710
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Completed
- Conditions
- PneumoniaUrinary Tract InfectionAbdominal Infection
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 16
- Registration Number
- NCT01414959
- Locations
- 🇦🇹
Med. Univ. of Vienna, Vienna, Austria
Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease
- Conditions
- Therapy Refractory Myocardial IschemiaCoronary Artery DiseaseUnsuitable for Surgical or Percutaneous Revascularisation
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2011-08-01
- Lead Sponsor
- Medical University of Vienna
- Registration Number
- NCT01406535
- Locations
- 🇦🇹
Rudolf Berger, MD, Vienna, Austria
Gingival Clefts and Orthodontic Movement
Not Applicable
- Conditions
- Orthodontic MovementGingival CleftsExtraction Socket
- Interventions
- Other: time point of tooth extraction
- First Posted Date
- 2011-07-26
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 25
- Registration Number
- NCT01402323
- Locations
- 🇦🇹
Bernhard Gottlieb School of Dentistry, Medical University of Vienna, Vienna, Austria
Pressure-wire Guided PTCA: Drug Eluting Stent Versus Drug Eluting Balloon (WinDEB Study)
Not Applicable
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Angioplasty performed via Paclitaxel Eluting Balloon catheterDevice: Angioplasty via DES
- First Posted Date
- 2011-07-21
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Medical University of Vienna
- Registration Number
- NCT01399463
Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine
Phase 4
Completed
- Conditions
- Humoral and Cellular Immune Responses
- Interventions
- Biological: IXIARO
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT01398540
© Copyright 2025. All Rights Reserved by MedPath